Dr. Reddy’s Laboratories (RDY) announced that it has entered into an exclusive partnership with Sanofi Healthcare India (SNY) to promote and distribute Sanofi’s vaccine brands across private markets in India. Under the arrangement, Dr. Reddy’s will have exclusive rights to promote and distribute Sanofi’s pediatric and adult vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim. Sanofi will continue to own, manufacture, and import these brands to the country.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RDY:
